N-Acetyl-L-ornithine

CAS No. 6205-08-9

N-Acetyl-L-ornithine( N-Acetylornithine | Acetyl-ornithine )

Catalog No. M19991 CAS No. 6205-08-9

N-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 43 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Acetyl-L-ornithine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L.
  • Description
    N-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L. Urine contains a very small amount of acetylornithine approximately 1 nmol/mg creatinine (1 μmol/day).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-Acetylornithine | Acetyl-ornithine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6205-08-9
  • Formula Weight
    174.2
  • Molecular Formula
    C7H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    Water:97.6 mM
  • SMILES
    CC(=O)N[C@@H](CCCN)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sreekumar A et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
molnova catalog
related products
  • 3,4,5-Tricaffeoylqui...

    3,4,5-Tricaffeoylquinic acid may attenuate the TNF-α±- and LPS-stimulated production of inflammatory mediators in keratinocytes by suppressing the Toll-like receptor 4 expression-mediated activation of the Akt, ERK and NF-κB pathways, it may exert an inhibitory effect against the pro-inflammatory mediator-induced skin disease.

  • 2,3-Dehydrosilychris...

    2,3-Dehydrosilychristin might have a biologically relevant inhibitory effect on ADH and glutamate dehydrogenase.

  • Nimustine Hydrochlor...

    Nimustine has been used in trials studying the treatment of Glioblastoma.